Phase I Single Dose Pharmacokinetic Trial of an Encapsulated Ginger Standardized to 5%-6-Gingerols

Principal Investigator:

Suzanna Zick, N.D.
Department of Family Medicine, University of Michigan Integrative Medicine

Co-Principal Investigator(s):

• Daniel Normolle, Ph.D. - Radiation Oncology, University of Michigan
• Mack Ruffin, M.D., MPH - Family Medicine, University of Michigan
• Dean Brenner, M.D. - Internal Medicine, University of Michigan
• D. Kim Turgeon, M.D., FACP - Internal Medicine/Gastroenterology, University of Michigan

Funding sources:

University of Michigan General Clinical Research Center

Time period for subject recruitment (start/end dates):

03/10/04 - 02/28/06

Abstract:

The purpose of this study is to examine the single-dose pharmacokinetics and acute safety of several doses of ginger powder.

Top of page